Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Levomilnacipran Extended-Release Capsules bulk supplier for pharma manufacturers

Levomilnacipran Extended-Release Capsules 20 mg, 40 mg, 80 mg, 120 mg Suppliers & Bulk Manufacturers

Available Forms: Extended-Release Capsules

Available Strengths: 20 mg, 40 mg, 80 mg, 120 mg

Reference Brands: Fetzima®(US)

Category: Psychiatry / Mental Health

Levomilnacipran is a serotonin-norepinephrine reuptake inhibitor (SNRI) that increases levels of these neurotransmitters in the brain to improve mood and energy. It is used for the treatment of major depressive disorder (MDD) in adults. The extended-release formulation allows for once-daily dosing and provides consistent therapeutic levels throughout the day.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Levomilnacipran extended-release (ER) capsules are FDA-approved in the United States for the treatment of major depressive disorder (MDD) in adults. As a serotonin-norepinephrine reuptake inhibitor (SNRI), the ER formulation provides consistent plasma levels and once-daily dosing. U.S. regulations mandate boxed warnings for increased suicidal thoughts in young adults, GMP-compliant manufacturing, bioequivalence studies for generics, and post-marketing pharmacovigilance. In the European Union, levomilnacipran is not widely marketed, but companies may pursue national or decentralized procedures for approval. EU requirements include a comprehensive Risk Management Plan (RMP), clinical safety and efficacy data, and robust pharmacovigilance measures. For dossier-ready sourcing, visit Pharmatradz.com.

Levomilnacipran Extended-Release Capsules — third party manufacturing & bulk supply

Levomilnacipran Extended-Release Capsules 20 mg, 40 mg, 80 mg, 120 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Levomilnacipran Extended-Release Capsules listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Levomilnacipran Extended-Release Capsule... →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Levomilnacipran is used to treat major depressive disorder (MDD) in adults. It helps improve mood, increase energy, and relieve other symptoms of depression such as loss of interest, fatigue, and difficulty concentrating.

Levomilnacipran is a synthetic pharmaceutical compound that acts as a serotonin-norepinephrine reuptake inhibitor (SNRI). It works by increasing the levels of serotonin and norepinephrine in the brain to restore neurotransmitter balance and alleviate depressive symptoms.

Levomilnacipran is marketed under the brand name Fetzima in the United States and other approved markets.

Levomilnacipran (Fetzima) is manufactured and marketed by Allergan / Forest Laboratories and distributed in multiple countries through authorized partners.

The generic name is Levomilnacipran.

The most recognized brand name is Fetzima.

Levomilnacipran is manufactured in regulated pharmaceutical facilities that comply with international quality and safety standards, including sites in the United States and other approved markets.

Related Products

Esketamine

Strength:
28 mg

Form: Nasal spray

Reference Brands: Spravato (USA/EU)

View Details
Agomelatine

Strength:
25 mg, 50 mg

Form: Tablets

Reference Brands: Valdoxan (EU/UK), Thymanax (India/ Middle East)

View Details
Bupropion Hydrobromide

Strength:
75 mg, 100 mg, 150mg, 300 mg

Form: Tablets

Reference Brands: Wellbutrin (USA), Zyban (USA)

View Details
Brexpiprazole Tablets

Strength:
0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg

Form: Tablets

Reference Brands: Rexulti®(US & EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.